FMR LLC and Abigail P. Johnson filed Amendment No. 6 to their Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of common stock in Avalo Therapeutics Inc. as of October 30, 2026.
FMR LLC and Abigail P. Johnson filed Amendment No. 8 to their Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of common stock in Penguin Solutions Inc. as of an October 30, 2026 triggering event.
FMR LLC and Abigail P. Johnson filed an amended Schedule 13G with the SEC on November 5, 2026, disclosing their beneficial ownership position in Natera Inc. common stock as of October 30, 2026.
FMR LLC and Abigail P. Johnson filed Amendment No. 3 to a Schedule 13G with the SEC on November 5, 2026, disclosing their beneficial ownership of Class A Common Stock in Braze Inc. as of October 30, 2026.
FMR LLC and Abigail P. Johnson filed an amended Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of approximately 10.4% of the common stock of Lovesac as of an October 30, 2026 triggering event.
FMR LLC and Abigail P. Johnson filed Amendment No. 2 to a Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of common stock in National Vision Holdings Inc. as of an event date of October 30, 2026.
FMR LLC and Abigail P. Johnson filed a Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of 667,465 shares of Gossamer Bio Inc. common stock as of October 30, 2026.
FMR LLC and Abigail P. Johnson filed Amendment No. 3 to a Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of common stock in Hillman Solutions Corp as of October 30, 2026.
FMR LLC and Abigail P. Johnson filed Amendment No. 7 to their Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of Class A Common Stock in UWM Holdings Corp as of October 30, 2026.
FMR LLC and Abigail P. Johnson filed a Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of 37,861,566 shares of common stock in MiniMed Group Inc., representing 13.5% of the class, as of an event date of October 30, 2026.